Diisothiocyanate-Derived Mercapturic Acids Are a Promising Partner for Combination Therapies in Glioblastoma

por Xu, Pengfei, Westhoff, Mike-Andrew, Hadzalic, Amina, Debatin, Klaus-Michael, Winiarski, Lukasz, Oleksyszyn, Jozef, Wirtz, Christian Rainer, Knippschild, Uwe, Burster, Timo
Publicado 2022

Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy

por Westhoff, Mike-Andrew, Schuler-Ortoli, Marie, Zerrinius, Daniela, Hadzalic, Amina, Schuster, Andrea, Strobel, Hannah, Scheuerle, Angelika, Wong, Tiana, Wirtz, Christian Rainer, Debatin, Klaus-Michael, Peraud, Aurelia
Publicado 2022

The limitations of targeting MEK signalling in Glioblastoma therapy

por Selvasaravanan, Karthika D., Wiederspohn, Nicole, Hadzalic, Amina, Strobel, Hannah, Payer, Christel, Schuster, Andrea, Karpel-Massler, Georg, Siegelin, Markus D., Halatsch, Marc-Eric, Debatin, Klaus-Michael, Westhoff, Mike-Andrew
Publicado 2020